Loading clinical trials...
Loading clinical trials...
The purpose of this study is to study how CMVIG interacts with the body and to see if it might work to prevent kidney transplant patients from becoming infected with CMV.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Minnesota
NCT07531966 · Kidney Transplant Recipient, Kidney Transplant; Complications, and more
NCT06059664 · Kidney Transplant; Complications
NCT06439342 · Cytomegalovirus (CMV)
NCT07235683 · CMV, Lung Transplant Recipient
NCT06958796 · Cytomegalovirus, Organ Transplant, and more
University of Minnesota
Minneapolis, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions